Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

 v2.3.0.11
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands
3 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net income $ 21,131 $ 4,602
Reconciliation of net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 594 782
Exchange (gain) loss 2 24
Deferred taxes 11,773  
Restructuring 245  
Gain on sale of CNS assets (31,608)  
Stock-based compensation 335 268
Changes in assets and liabilities:    
Restricted Cash (3,350)  
Accounts receivable 5,096 (200)
Inventory 196 (249)
Prepaid expenses and other current assets (382) 712
Other assets and liabilities (9) 212
Deferred revenue 270 22
Accounts payable and accrued expenses (12,633) (3,151)
Accrued compensation (2,273) (2,015)
Net cash provided by (used in) operating activities (10,613) 1,007
Cash flows from investing activities:    
Sales of investments 490  
Purchases of investments (5,155)  
Purchases of property and equipment (335) (142)
Proceeds from sale of CNS assets 36,637  
Net cash provided by (used in) investing activities 31,637 (142)
Cash flows from financing activities:    
Purchases of treasury stock (6,327) (370)
Proceeds from stock options exercised 1,206 48
Net cash provided by (used in) financing activities (5,121) (322)
Effect of exchange rate changes on cash 20 (87)
Net increase in cash 15,923 456
Cash and cash equivalents, beginning of period 86,408 61,315
Cash and cash equivalents, end of period $ 102,331 $ 61,771